Thomas H. Lee Partners
http://www.thl.com/index.htmlThomas H. Lee Partners, also known as THL Partners, is a private equity firm founded in 1974 by Thomas H. Lee. As one of the oldest and most successful private equity firms since its inception, THL has raised approximately $22 billion of equity capital, invested in more than 100 businesses with a $125 billion aggregate purchase price, and completed over 200 add-on transactions. The industries the firm focuses on include: Business and Information Services, Consumer Products/Retail, Financial Services, Health Care, Industrial, and Media/Communications. THL’s successes have included the 1985 acquisition of Sterling Jewelers and 1992 acquisition of Snapple Beverages.
View Older Stories View More Recent Stories
-
inVentiv Health CEO to Present at J.P. Morgan Healthcare Conference
-
AEA Investors to Acquire a Majority Interest of 1-800 Contacts
-
Thomas H. Lee Partners Invests Growth Capital in Bargain Hunt Superstores
-
Aramark Reports Strong Fourth Quarter and Full Year 2015 Results
-
Blackstone (BX) Agrees to Sell GCA Services Group
-
Thomas H. Lee Partners and Goldman Sachs to Acquire GCA Services Group
-
Blackstone to Sell GCA Services Group to Thomas H. Lee Partners and Goldman Sachs
-
A10 Capital Closes $67 Million Bridge Loan on a Value-Add Portfolio
-
A10 Capital Closes $67 Million Bridge Loan on a Value-Add Portfolio
-
MoneyGram International Reports Third Quarter 2015 Financial Results
-
Black Knight Financial Services Reports Third Quarter 2015 Financial Results
-
Franklin Square Announces Senior Secured Financing for Healthcare Staffing Services
-
Blackrock and THL Credit Make Follow-On Investment in A10 Capital
-
Blackrock and THL Credit Make Follow-On Investment in A10 Capital
-
Thomas H. Lee Partners Completes Acquisition of Majority Stake in Healthcare Staffing Services
-
Xerox Expands Pharma Portfolio with Acquisition of inVentiv Patient Access Solutions
-
Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials
-
Notable 52-Week Highs and Lows 8/19: (ARMK) (HRL) (PGR) Higher; (WMT) (RYAM) (CSTE) Lower
-
Aramark Services (ARMK) Announces 22.5M Common Secondary Offering; Plans 1.5M Common Stock Buyback
-
Aramark Announces Secondary Common Stock Offering and Concurrent Company Share Repurchase from Selling Stockholders of 1.5 Million Shares
-
Aramark Reports Third Quarter 2015 Results
-
inVentiv Health Executives Named To PharmaVOICE 100 List Of Most Inspiring Leaders
-
MoneyGram (MGI) Appoints New CEO
-
MoneyGram International Reports Second Quarter 2015 Financial Results
-
MoneyGram International Reports Second Quarter 2015 Financial Results
-
MoneyGram Announces Leadership Succession Plan
-
Black Knight Financial Services Reports Second Quarter 2015 Financial Results
-
Market Wrap: Markets Rebound on Eased China Fears; P&G to Sell Beauty Assets; Jobless Claims Pop Higher
-
Thomas H. Lee in the lead to buy eBay's enterprise unit: sources
-
Kainos Capital Promotes Daniel Hopkin and Nirav Shah to Partner
-
UPDATE: Jefferies Starts THL Credit (TCRD) at Hold
-
West Corp. (WSTC) Closes 7M Common Stock Secondary Offering; Repurchased 1M Common at $30.36/Share
-
West Corporation Announces Closing of Secondary Offering of Common Stock and Share Repurchase
-
West Corporation Announces Closing of Secondary Offering of Common Stock and Share Repurchase
-
A10 Capital Wins EY Entrepreneur Of The Year 2015 Award in the Utah Region
-
A10 Capital Wins EY Entrepreneur Of The Year 2015 Award in the Utah Region
-
Pre-Open Stock Movers 06/19 (AMCN) (AERI) (CAG) Higher; (SARA) (HWAY) (TKMR) Lower (more...)
-
After-Hours Stock Movers 06/18: (CAG) (SLI) (FNSR) Higher; (HWAY) (SWHC) (RHT) Lower (more...)
-
West Corp. (WSTC) Announces 7M Secondary Common Offering, 1M Share Repurchase
-
West Corporation Announces Secondary Offering of Common Stock and Share Repurchase
-
West Corporation Announces Secondary Offering of Common Stock and Share Repurchase
-
Campbell Alliance Survey Of Biopharmaceutical Dealmakers Suggests 2015 Will Set A New Record For M&A Licensing
-
Campbell Alliance Report On 2015 Trends In Biopharmaceutical Dealmaking Reveals Areas Of Greatest Opportunity For Buyers And Sellers
-
Prime Risk Partners Acquires Cook Maran & Associates
-
inVentiv Health Names Dr. Michael McKelvey President, Clinical Division And Executive Vice President, inVentiv Health
-
Patient Advocacy Groups Say Relationships with Pharmaceutical Companies Must Evolve to Keep Pace with Significant Changes in Healthcare Industry
-
A10 Capital Provides Over $9MM in Bridge Funding for Two Suburban Office Buildings
-
Aramark Services (ARMK) Announces 25M Common Secondary Offering
-
Aramark Announces Secondary Common Stock Offering
-
inVentiv Health Expands Global Regulatory And Compliance Services For Pharmaceutical Companies Conducting Non-Interventional Studies

